Monthwise SARS CoV-2 mutation statistics
Position | Mutation | Clade |
---|---|---|
433 | nsp4:D433-; | CL-3b;CL-3f; |
433 | nsp4:D433G; | CL-3e; |
477 | nsp4:D477A; | CL-1a_3d;CL-3b;CL-3d; |
477 | nsp4:D477Y; | CL-2; |
484 | nsp4:D484-; | CL-3e; |
50 | nsp4:D50G; | CL-3e; |
70 | nsp4:D70G; | CL-3b;CL-3e;CL-3f; |
70 | nsp4:D70N; | CL-1a; |
72 | nsp4:D72N; | CL-2; |
72 | nsp4:D72Y; | CL-1a; |
85 | nsp4:D85-; | CL-3b;CL-3d; |
85 | nsp4:D85E; | CL-3e; |
85 | nsp4:D85Y; | CL-3f; |
141 | nsp4:E141-; | CL-3d; |
141 | nsp4:E141G; | CL-3e; |
155 | nsp4:E155-; | CL-1a;CL-3e; |
183 | nsp4:E183-; | CL-3e; |
183 | nsp4:E183D; | CL-3f; |
183 | nsp4:E183G; | CL-3c;CL-3d;CL-3f; |
219 | nsp4:E219-; | CL-3b;CL-3e; |
227 | nsp4:E227-; | CL-3b;CL-3e; |
227 | nsp4:E227D; | CL-1a; |
230 | nsp4:E230G; | CL-1a;CL-3b;CL-5; |
230 | nsp4:E230K; | CL-3e; |
310 | nsp4:E310-; | CL-1a_3d;CL-1b;CL-3a;CL-3b;CL-3e; |
310 | nsp4:E310A; | CL-3b; |
310 | nsp4:E310G; | CL-1a;CL-1a_3f;CL-3b;CL-3e; |
413 | nsp4:E413K; | CL-3d; |
42 | nsp4:E42-; | CL-3e; |
425 | nsp4:E425-; | CL-2; |
425 | nsp4:E425D; | CL-3f; |
425 | nsp4:E425G; | CL-3e; |
42 | nsp4:E42D; | CL-3b; |
98 | nsp4:E98-; | CL-1a; |
101 | nsp4:F101L; | CL-1a;CL-3e; |
101 | nsp4:F101S; | CL-3b;CL-3f; |
118 | nsp4:F118L; | CL-3e; |
121 | nsp4:F121C; | CL-5; |
145 | nsp4:F145I; | CL-1a;CL-5; |
145 | nsp4:F145L; | CL-2; |
17 | nsp4:F17-; | CL-3e; |
19 | nsp4:F19V; | CL-3b; |
201 | nsp4:F201Y; | CL-3d; |
24 | nsp4:F24C; | CL-3e; |
24 | nsp4:F24V; | CL-3e; |
255 | nsp4:F255L; | CL-3e; |
255 | nsp4:F255Y; | CL-1a; |
268 | nsp4:F268Y; | CL-1a; |
301 | nsp4:F301L; | CL-3f; |
301 | nsp4:F301V; | CL-3b; |
Page 312 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com